Diagnosis of HER2 protein overexpression in patients with breast cancer in Brazil

被引：0
|
作者：
Muranaka, A. H. [1 ]
机构：
[1] Prod Roche Quim & Farmaceut SA, Sao Paulo, Brazil
来源：
VALUE IN HEALTH | 2008年 / 11卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)70181-9
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A54 / A54
页数：1
相关论文
共 50 条
  • [31] Co-overexpression of HER2/HER3 is a predictor of impaired survival in breast cancer patients
    Berghoff, Anna S.
    Bartsch, Rupert
    Preusser, Matthias
    Ricken, Gerda
    Steger, Guenther G.
    Bago-Horvath, Zsuzsanna
    Rudas, Margareta
    Streubel, Berthold
    Dubsky, Peter
    Gnant, Michael
    Fitzal, Florian
    Zielinski, Christoph C.
    Birner, Peter
    BREAST, 2014, 23 (05) : 637 - 643
  • [32] The predictive role of HER2 overexpression in early breast cancer - Reply
    Menard, S
    Biganzoli, E
    Valagussa, P
    Boracchi, P
    Moliterni, A
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (16) : 3180 - 3180
  • [33] Protein kinase cα determines HER2 fate in breast carcinoma cells with HER2 protein overexpression without gene amplification
    Magnifico, Alessandra
    Albano, Luisa
    Campaner, Stefano
    Campiglio, Manuela
    Pilotti, Silvana
    Menard, Sylvie
    Tagliabue, Elda
    CANCER RESEARCH, 2007, 67 (11) : 5308 - 5317
  • [34] Lapatinib in the treatment of brain metastases in patients with breast cancer with overexpression or amplification of the HER2 gene
    Duchnowska, Renata
    ONCOLOGY IN CLINICAL PRACTICE, 2011, 7 : D6 - D9
  • [35] HER2 Gene Protein Assay Is Useful to Determine HER2 Status and Evaluate HER2 Heterogeneity in HER2 Equivocal Breast Cancer
    Hou, Yanjun
    Nitta, Hiroaki
    Li, Zaibo
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2017, 147 (01) : 89 - 95
  • [36] In situ detection of HER2:HER2 and HER2:HER3 protein–protein interactions demonstrates prognostic significance in early breast cancer
    Melanie Spears
    Karen J. Taylor
    Alison F. Munro
    Carrie A. Cunningham
    Elizabeth A. Mallon
    Chris J. Twelves
    David A. Cameron
    Jeremy Thomas
    John M. S. Bartlett
    Breast Cancer Research and Treatment, 2012, 132 : 463 - 470
  • [37] A prospective study to assess the clinical utility of serum HER2 extracellular domain in breast cancer with HER2 overexpression
    Nathalie Reix
    Charlotte Malina
    Marie-Pierre Chenard
    Jean-Pierre Bellocq
    Stéphanie Delpous
    Sébastien Molière
    Anthony Sevrin
    Karl Neuberger
    Catherine Tomasetto
    Carole Mathelin
    Breast Cancer Research and Treatment, 2016, 160 : 249 - 259
  • [38] A prospective study to assess the clinical utility of serum HER2 extracellular domain in breast cancer with HER2 overexpression
    Reix, Nathalie
    Malina, Charlotte
    Chenard, Marie-Pierre
    Bellocq, Jean-Pierre
    Delpous, Stephanie
    Moliere, Sebastien
    Sevrin, Anthony
    Neuberger, Karl
    Tomasetto, Catherine
    Mathelin, Carole
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 160 (02) : 249 - 259
  • [39] Molecular targeting of HER2 for diagnosis and therapy of breast cancer
    Capala, J.
    Kramer-Marek, G.
    Lee, S. B.
    Hassan, M.
    Kiesewetter, D. O.
    Puri, A.
    Chernomordik, V
    Gandjbakhche, A.
    Griffiths, G.
    Blumenthal, R.
    CANCER RESEARCH, 2009, 69 (02) : 349S - 349S
  • [40] Robust and accurate digital measurement for HER2 amplification in HER2 equivocal breast cancer diagnosis
    Yuefeng Wang
    Julia Y. S. Tsang
    Yongmei Cui
    Ji Cui
    Ying Lin
    Songli Zhao
    Patrick T. W. Law
    Sai Yin Cheung
    Enders K. O. Ng
    Gary M. K. Tse
    Zunfu Ke
    Scientific Reports, 7
12345